GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that the use of glp-1 is associated with a lower risk of colon cancer compared to aspirin. This finding implies a potential difference in the effectiveness of these two substances in reducing colon cancer risk. The study indicates that glp-1 may have a beneficial effect in this regard.